Rapid Micro Biosystems Inc (NAS:RPID)
$ 1.71 -0.030 (-1.72%) Market Cap: 85.20 Mil Enterprise Value: 88.91 Mil PE Ratio: 0 PB Ratio: 3.80 GF Score: 56/100

Q4 2024 Rapid Micro Biosystems Inc Earnings Call Transcript

Feb 28, 2025 / 01:00PM GMT
Release Date Price: $3.05 (-7.85%)

Key Points

Positve
  • Rapid Micro Biosystems Inc (RPID) reported a 30% year-over-year revenue growth in Q4 2024, reaching a record $8.2 million.
  • The company placed six Growth Direct systems in Q4, bringing the total to 21 system placements for the full year.
  • Gross margins improved to 12% in Q4, up from 8% in the previous quarter, reflecting progress in cost structure and operating leverage.
  • A new global distribution and collaboration agreement with Millipore Sigma is expected to enhance system placements and improve supply chain efficiencies.
  • The partnership with Millipore Sigma is anticipated to significantly expand Growth Direct's reach and increase its total addressable market.
Negative
  • Despite the revenue growth, the company reported a net loss of $9.7 million in Q4 2024.
  • Product margins were only 8% in Q4, a decrease from 14% in Q4 2023.
  • The guidance for 2025 does not assume any contribution from the Millipore Sigma partnership, reflecting uncertainty in immediate impact.
  • There is ongoing uncertainty around the timing and scale of customer purchase decisions, particularly for larger multi-system opportunities.
  • The company expects to burn approximately $30 million in cash for the full year 2025, indicating continued financial pressure.
Operator

Thank you for standing by. My name is Eloisa, and I will be your conference operator today. At this time, I would like to welcome everyone to the Rapid Micro Biosystems' fourth quarter and full year 2024 earnings conference call. All lines have been placed on mute to prevent any background noise. After the speakersâ remarks there will be a question and answer session. (Operator Instructions)

Thank you. I would now like to turn the call over to Mike Bowler. Please go ahead.

Michael Beaulieu
Rapid Micro Biosystems Inc - Vice President, Investor Relations & Corporate Communications

Good morning, and thank you for joining the Rapid Micro Biosystemsâ fourth quarter and full year 2024 earnings call. Joining me on the call are Rob Spignesi, President and Chief Executive Officer; and Sean Wirtjes, Chief Financial Officer.

Earlier today, we issued a press release announcing our fourth quarter and full year 2024 financial results. Additionally, last night in a separate release, we announced a distribution and collaboration agreement with the life

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot